Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
498.00    -16.00 (-3.11%)
Bid:
498.00
Ask:
506.00
Spread: 8.00 (1.606%)
Market Cap: £251.41m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

Director/PDMR Shareholding

3 Apr 2009 12:37

RNS Number : 1134Q
Fisher (James) & Sons PLC
03 April 2009
Β 

3Β April 2009

James Fisher and Sons Public Limited Company ("the Company")

Directors interest inΒ shares

The Company has granted options to the executive directors of the Company under the Long Term Incentive Plan (2001) which was approved by shareholders in April 2001 and the Executive Share Option Scheme (2005) which was approved by shareholders on 29 April 2005 and the Inland Revenue on 17 June 2005.

Long Term Incentive Plan

The options granted under the Long Term Incentive Plan have been granted at an exercise price of nil cost. The award is granted subject to the performance conditions stipulated in the scheme rules and the option is exercisable on 31 March 2012 assuming that the performance conditions are met.

No consideration was paid for the grant of options.

Executive Share Option Scheme

The options granted under the Executive Share Option Scheme have been granted at a price of 354p per share, being the average middle market price of a share over the three dealing days immediately preceding the date of grant. The award is granted subject to the performance conditions stipulated in the scheme rules and the option is exercisable from 20 March 2012 to 20 March 2019 assuming that the performance conditions are met.

Details of the award under each of these schemes are as follows:

Number of Ordinary SharesΒ under Option pursuant to the LTIP prior to the award

Options Granted over Ordinary Shares pursuant to the LTIP

Total number of Ordinary Shares under Option pursuant to the LTIP

T.C.Harris

46,606

71,747

118,353

N.P.Henry

45,422

45,775

91,197

M.J.Shields

22,148

33,908

56,056

S.A.Harris

18,703

27,465

46,168

Number of Ordinary SharesΒ under Option pursuant to the Executive Share Option Scheme prior to the award

Options Granted over Ordinary Shares pursuant to the Executive Share Option Scheme

Total number of Ordinary Shares under Option pursuant to the Executive Share Option Scheme

T.C.Harris

340,130

103,107

443,237

N.P.Henry

131,474

65,784

197,258

M.J.Shields

101,555

48,729

150,284

S.A.Harris

73,301

39,470

112,771

The Company was notified on 1 April 2009 that Mr M.J.Shields an executive director of the Company has sold 5,100 Ordinary Shares in the Company at a price of Β£3.90. Following this transaction Mr Shields has a beneficial interest in the company's issued share capital of 195,166 Ordinary Shares representing 0.39 per cent of the Company's issued ordinary share capital.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSIJMBTMMJMBAL
Date   Source Headline
22nd May 202612:22 pmRNS-RNotice of Defence Division Investor Event
18th May 20269:30 amRNSDirector/PDMR Shareholding
13th May 20261:48 pmRNSResult of AGM
22nd Apr 202611:15 amRNSDirector/PDMR Shareholding
8th Apr 20269:28 amRNSAnnual Report and Accounts and Notice of AGM
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
16th Feb 20267:00 amRNSNotice of Analyst and Investor Presentations
13th Feb 20263:10 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
27th Jan 20262:05 pmRNSHolding(s) in Company
15th Jan 20262:00 pmRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20254:08 pmRNSHolding(s) in Company
26th Sep 20258:35 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSHalf Year Results
21st Aug 20257:00 amRNSNotice of Analyst and Investor Presentations
1st Aug 20258:00 amRNSTotal Voting Rights and Share Capital
29th Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
16th Jul 20257:00 amRNSTotal Voting Rights and Share Capital
16th Jun 20254:35 pmRNSBlock listing six monthly return
23rd May 202511:46 amRNSBlock Listing Application
13th May 20252:36 pmRNSResults of Annual General Meeting
6th May 202510:39 amRNSNotification of Directors' Interest in Shares
28th Apr 20252:33 pmRNSNotification of Directors' Interest in Shares
4th Apr 20259:30 amRNSAnnual Report and Accounts 2024 and Notice of AGM
20th Mar 20257:00 amRNSFull Year Results
14th Mar 20259:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20257:56 amRNSHolding(s) in Company
16th Jan 20259:58 amRNSHolding(s) in Company
16th Dec 202410:59 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Sep 20243:35 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSSigning of £95m of committed bank facilities
10th Sep 20247:00 amRNSHalf year results
6th Sep 20242:10 pmRNSCompletion of Disposal of Martek Holdings Limited
8th Jul 20244:19 pmRNSHolding(s) in Company
8th Jul 202410:04 amRNSCompletion of RMSpumptools Disposal
28th Jun 20249:26 amRNSDirector Declaration
17th Jun 202411:32 amRNSBlock listing six monthly return
13th Jun 20246:15 pmRNSResults of the General Meeting
12th Jun 20241:43 pmRNSNotification of Directors' Interests in Shares
30th May 20244:48 pmRNSResults of Annual General Meeting
30th May 20243:34 pmRNSDirector Declaration
24th May 20243:18 pmRNSPublication of Circular and Notice of GM
29th Apr 20245:39 pmRNSAnnual Report and Accounts 2023 and Notice of AGM
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.